Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks
Open accessThe DOI matches its Crossref record; 221 of the 221 references it cites were found in a registry or an index.
Abstract
Staphylococcus aureus has long been recognized as an important pathogen in human disease. Due to an increasing number of infections caused by methicillin-resistant S. aureus (MRSA) strains, therapy has become problematic. Therefore, prevention of staphylococcal infections has become more important. Carriage of S. aureus appears to play a key role in the epidemiology and pathogenesis of infection. The ecological niches of S. aureus are the anterior nares. In healthy subjects, over time, three patterns of carriage can be distinguished: about 20% of people are persistent carriers, 60% are intermittent carriers, and approximately 20% almost never carry S. aureus. The molecular basis of the carrier state remains to be elucidated. In patients who repeatedly puncture the skin (e.g., hemodialysis or continuous ambulatory peritoneal dialysis [CAPD] patients and intravenous drug addicts) and patients with human immunodeficiency virus (HIV) infection, increased carriage rates are found. Carriage has been identified as an important risk factor for infection in patients undergoing surgery, those on hemodialysis or CAPD, those with HIV infection and AIDS, those with intravascular devices, and those colonized with MRSA. Elimination of carriage has been found to reduce the infection rates in surgical patients and those on hemodialysis and CAPD. Elimination of carriage appears to be an attractive preventive strategy in patients at risk. Further studies are needed to optimize this strategy and to define the groups at risk.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“People who misuse drugs have a higher rate of nasal or skin colonization with S. aureus than the general population (2, 14).”
From Methicillin-Resistant Staphylococcus aureus Nasal Carriage among Injection Drug Users: Six Years Later (2008) · cites this paper as [14]
In the citing paper
“S. aureus nasal carriage, present in about 20% of the general population, has been identified as a risk factor for the subsequent development of community-acquired and nosocomial staphylococcal infections (14, 22).”
From Methicillin-Resistant Staphylococcus aureus Nasal Carriage among Injection Drug Users: Six Years Later (2008) · cites this paper as [14]
In the citing paper
“S. aureus nasal carriage, present in about 20% of the general population, has been identified as a risk factor for the subsequent development of community-acquired and nosocomial staphylococcal infections (14, 22).”
From Methicillin-Resistant Staphylococcus aureus Nasal Carriage among Injection Drug Users: Six Years Later (2008) · cites this paper as [14]
In the citing paper
“Carriage of S. aureus is a significant risk factor for nosocomial invasive infections by S. aureus (Kluytmans et al., 1997).”
From Nasal Microenvironments and Interspecific Interactions Influence Nasal Microbiota Complexity and S. aureus Carriage (2013) · cites this paper as Kluytmans et al., 1997
Citations
Cites
An overview of nosocomial infections, including the role of the microbiology laboratory
Emori, T. G., & Gaynes, R. P. (1993) · Clinical Microbiology Reviews · doi:10.1128/cmr.6.4.428 · Cited by 1,286 · cited 1×
“In 1992, resistance had increased to nearly 8% (66).”
BackgroundThe Spectrum of Vasculitis: Clinical, Pathologic, Immunologic, and Therapeutic Considerations
FAUCI, A. S., HAYNES, B. F., & KATZ, P. (1978) · Annals of Internal Medicine · doi:10.7326/0003-4819-89-5-660 · Cited by 1,196 · cited 1×
“Wegener’s granulomatosis is a systemic disease characterized by necrotizing granulomatous inflammation of the upper and lower respiratory tract in combination with vasculitis and focal necrotizing crescentic glomerulonephritis (52).”
BackgroundMSCRAMM-MEDIATED ADHERENCE OF MICROORGANISMS TO HOST TISSUES
Patti, J. M., Allen, B. L., McGavin, M. J., & Höök, M. (1994) · Annual Review of Microbiology · doi:10.1146/annurev.mi.48.100194.003101 · Cited by 1,191
Major trends in the microbial etiology of nosocomial infection
Schaberg, D. R., Culver, D. H., & Gaynes, R. P. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90346-y · Cited by 1,109 · cited 1×
“aureus is the second most prevalent organism causing intravascular device-associated bacteremia (111, 165).”
BackgroundMethicillin-ResistantStaphylococcus aureus in Europe
Voss, A., Milatovic, D., Wallrauch-Schwarz, C., Rosdahl, V. T., & Braveny, I. (1994) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf02026127 · Cited by 801
Stegeman, C. A., Tervaert, J. W. C., Sluiter, W. J., Manson, W. L., de Jong, P. E., & Kallenberg, C. G. M. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-1-199401010-00003 · Cited by 729
Prevention and Control of Nosocomial Infections.
(1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-5-791_4 · Cited by 719
Methicillin-Resistant Staphylococcus aureus in U.S. Hospitals, 1975–1991
Panlilio, A. L., Culver, D. H., Gaynes, R. P., Banerjee, S., Henderson, T. S., Tolson, J. S., Martone, W. J., & System, N. N. I. S. (1992) · Infection Control & Hospital Epidemiology · doi:10.1086/646432 · Cited by 657
Mulligan, M. E., Murray-Leisure, K. A., Ribner, B. S., Standiford, H. C., John, J. F., Korvick, J. A., Kauffman, C. A., & Yu, V. L. (1993) · The American Journal of Medicine · doi:10.1016/0002-9343(93)90063-u · Cited by 641
Noble, W. C., Virani, Z., & Cree, R. G. A. (1992) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1992.tb05089.x · Cited by 627
Cited by
Items 601–700 of 1,002
Onanuga, A., Oyi, A. R., & Onaolapo, J. A. (2005) · AFRICAN JOURNAL OF BIOTECHNOLOGY · doi:10.5897/ajb2005.000-3261 · Cited by 53
Neomycin Sulfate Improves the Antimicrobial Activity of Mupirocin-Based Antibacterial Ointments
Blanchard, C. E., Brooks, L. R., Beckley, A., Colquhoun, J. M., Dewhurst, S., & Dunman, P. M. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02083-15 · Cited by 53
“aureus nasal decolonization reduces colonization of other body sites, the risk of transmission, and subsequent infection (5).”
BackgroundPlano, L. R. W., Shibata, T., Garza, A. C., Kish, J. K., Fleisher, J. M., Sinigalliano, C. D., Gidley, M. L., Withum, K. F., Elmir, S. M., Hower, S., et al. (2013) · Microbial Ecology · doi:10.1007/s00248-013-0216-1 · Cited by 53
“aureus, colonizations are often transient in nature [2].”
BackgroundGilot, P., & van Leeuwen, W. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.3.1265-1269.2004 · Cited by 53
“Staphylococcus aureus is an important cause of a variety of diseases in humans and animals and is a large economic problem worldwide (9, 14).”
BackgroundFerens, W. A., & Bohach, G. A. (2000) · Journal of Laboratory and Clinical Medicine · doi:10.1067/mlc.2000.105179 · Cited by 53
Dalman, M. R., Bhatta, S., Nagajothi, N., Thapaliya, D., Olson, H., Naimi, H. M., & Smith, T. C. (2019) · BMC Infectious Diseases · doi:10.1186/s12879-019-3699-7 · Cited by 52
DISCORDANCE BETWEEN STAPHYLOCOCCUS AUREUS NASAL COLONIZATION AND SKIN INFECTIONS IN CHILDREN
Chen, A. E., Cantey, J. B., Carroll, K. C., Ross, T. L., Speser, S., & Siberry, G. K. (2009) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31818cb0c4 · Cited by 52
“aureus and a potential source for spreading organisms to other people.(2) Large population-based studies have estimated that the adult nasal carriage rate of S.”
BackgroundSeni, J., Bwanga, F., Najjuka, C. F., Makobore, P., Okee, M. S., Mshana, S. E., Kidenya, B. R., Joloba, M. L., & Kateete, D. P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066153 · Cited by 52
“aureus carriage is the most important factor predisposing colonized individuals to subsequent SSI; other factors are longer duration of hospital stay, HIV infection, cancer, and opsonic defects [2,3].”
BackgroundHaisma, E. M., Göblyös, A., Ravensbergen, B., Adriaans, A. E., Cordfunke, R. A., Schrumpf, J. A., Limpens, R. W. A. L., Schimmel, K. J. M., den Hartigh, J., Hiemstra, P. S., et al. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03001-15 · Cited by 52
Staphylococcus aureus targets the purine salvage pathway to kill phagocytes
Winstel, V., Missiakas, D. M., & Schneewind, O. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1805622115 · Cited by 52
“aureus colonization represents a key risk factor for invasive disease, which in hospital environments frequently manifests as surgical wound and medical device infections or ventilatorasscociated pneumonia (4, 5).”
BackgroundRihn, J. A., Michaels, M. G., & Harner, C. D. (2005) · The American Journal of Sports Medicine · doi:10.1177/0363546505283273 · Cited by 52
“Approximately 30% of healthy, asymptomatic people and as many as 65% of patients with staphylococcal skin infections carry S aureus in their anterior nares.(28) Transmission is thought to occur through direct person-to-person contact, when open skin wounds are exposed to bacteria from an infected lesion or from the se…”
BackgroundStaphylococcus aureus in Inflammation and Pain: Update on Pathologic Mechanisms
Rasquel-Oliveira, F. S., Ribeiro, J. M., Martelossi-Cebinelli, G., Costa, F., Nakazato, G., Casagrande, R., & Verri, W. A., Jr. (2025) · Pathogens · doi:10.3390/pathogens14020185 · Cited by 51
Vincze, S., Brandenburg, A. G., Espelage, W., Stamm, I., Wieler, L. H., Kopp, P. A., Lübke‐Becker, A., & Walther, B. (2014) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2014.07.007 · Cited by 52
MRSA as an occupational disease: a case series
Haamann, F., Dulon, M., & Nienhaus, A. (2011) · International Archives of Occupational and Environmental Health · doi:10.1007/s00420-010-0610-7 · Cited by 51
“It is assumed that rates of MRSA carriage are higher among HCWs than in the broader community (Kluytmans et al. 1997).”
BackgroundInfluentialHayes, S. M., Howlin, R. P., Johnston, D. A., Webb, J. S., Clarke, S. C., Stoodley, P., Harries, P. G., Wilson, S. J., Pender, S. L. F., Faust, S. N., et al. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.12.1929 · Cited by 51
Creech, C. B., Saye, E. J., McKenna, B. D., Johnson, B. G., Jimenez, N., Talbot, T. R., Bossung, T., Gregory, A. J. M., & Edwards, K. M. (2010) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpediatrics.2010.93 · Cited by 51
“At the root of the problem is that S aureus is a ubiquitous microorganism, colonizing the anterior nares of nearly one-third of the entire human population at any given time.(2,3) However, S aureus does not remain merely a commensal; rather, it is the leading cause of skin, soft tissue, and bone infections and has a s…”
BackgroundChan, L. C., Chaili, S., Filler, S. G., Miller, L. S., Solis, N. V., Wang, H., Johnson, C. W., Lee, H. K., Diaz, L. F., & Yeaman, M. R. (2017) · Infection and Immunity · doi:10.1128/iai.00876-16 · Cited by 51
“However, epidemiological studies have demonstrated that persistent carriers are at increased risk for recurrent MRSA infections (42, 43), suggesting that antibodies directed against S.”
BackgroundSulaiman, F. A., Kazeem, M. O., Waheed, A. M., Temowo, S. O., Azeez, I. O., Zubair, F. I., Adeyemi, T. A., Nyang, A., & Adeyemı, O. S. (2014) · Journal of Taibah University for Science · doi:10.1016/j.jtusci.2014.05.004 · Cited by 51
Aires-de-Sousa, M., Santos‐Sanches, I., Ferro, M. L., & de LENCASTRE, H. (2000) · Microbial Drug Resistance · doi:10.1089/107662900419447 · Cited by 51
Nh125 Kills Methicillin-Resistant Staphylococcus Aureus Persisters by Lipid Bilayer Disruption
Kim, W., Fricke, N., Conery, A. L., Fuchs, B. B., Rajamuthiah, R., Jayamani, E., Vlahovska, P. M., Ausubel, F. M., & Mylonakis, E. E. (2016) · Future Medicinal Chemistry · doi:10.4155/fmc.15.189 · Cited by 51
Willers, C., Wentzel, J. F., Plessis, D., Gouws, C., & Hamman, J. H. (2016) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2017.1265105 · Cited by 51
Ikeda, R., Saito, F., Matsuo, M., Kurokawa, K., Sekimizu, K., Yamaguchi, M., & Kawamoto, S. (2007) · Journal of Bacteriology · doi:10.1128/jb.00412-07 · Cited by 51
“of healthy human subjects (28, 57), killed C.”
BackgroundWang, X., Ge, J., Liu, B., Hu, Y., & Yang, M. (2013) · Protein & Cell · doi:10.1007/s13238-013-3009-x · Cited by 50
“Staphylococcus aureus (S. aureus), widely distributed around the world (Kluytmans et al., 1997), is a major threat to humans leading to infections ranging from mild skin infections to severe syndromes including meningitis, pneumonia, endocarditis, bacteremia, osteomyelitis and sepsis…”
BackgroundCole, A. L., Muthukrishnan, G., Chong, C., Beavis, A., Eade, C. R., Wood, M. P., Deichen, M., & Cole, A. M. (2016) · Mucosal Immunology · doi:10.1038/mi.2016.2 · Cited by 50
Fetsch, A., Etter, D., & Johler, S. (2021) · Current Clinical Microbiology Reports · doi:10.1007/s40588-021-00170-y · Cited by 50
Gélinas, M., Museau, L., Milot, A., & Beauregard, P. B. (2021) · Microbiology Spectrum · doi:10.1128/spectrum.00804-21 · Cited by 50
“acquired in hospital or community environment (18).”
The induction of natural competence adapts staphylococcal metabolism to infection
Cordero, M., García‐Fernández, J., Acosta, I. C., Yepes, A., Ortiz, J. A., Lisowski, C., Oesterreicht, B., Ohlsen, K., López‐Collazo, E., Förstner, K. U., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29206-7 · Cited by 50
Adesida, S. A., Abioye, O. A., Bamiro, B. S., Brai, B. I. C., Smith, S. I., Amisu, K. O., Ehichioya, D. U., Ogunsola, F. T., & Coker, A. O. (2007) · The Brazilian Journal of Infectious Diseases · doi:10.1590/s1413-86702007000100016 · Cited by 50
“Basically, epidemiological pathways are from patients to healthcare worker to patients [8] and transmission to patients occurs during routine patient care [9].”
BackgroundA case-control study of mastitis: nasal carriage of Staphylococcus aureus
Amir, L. H., Garland, S. M., & Lumley, J. (2006) · BMC Family Practice · doi:10.1186/1471-2296-7-57 · Cited by 50
Treesirichod, A., Hantagool, S., & Prommalikit, O. (2013) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2012.12.004 · Cited by 50
“[1].”
BackgroundAntibacterial Prophylaxis in Dermatologic Surgery: An Evidence-Based Review
Rosengren, H., & Dixon, A. J. (2009) · American Journal of Clinical Dermatology · doi:10.2165/11311090-000000000-00000 · Cited by 49
“[1] Paying careful attention to aseptic technique, including preoperative hand washing practice, procedures for sterilizing instruments, and wound preparation, as well as using hats, gloves, and masks, and reducing traffic in the operating theater, are all recognized to be important in combating SSIs.”
BackgroundInfluentialSai, N., Laurent, C., Strale, H., Denis, O., & Byl, B. (2015) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-015-0096-x · Cited by 49
“up to 30 % of acquiring MRSA infection during hospital stays [3, 4].”
BackgroundJoachim, A., Moyo, S. J., Nkinda, L., Majigo, M. V., Mmbaga, E. J., Mbembati, N., Aboud, S., & Lyamuya, E. (2017) · BMC Research Notes · doi:10.1186/s13104-017-2668-8 · Cited by 49
von Köckritz‐Blickwede, M., & Winstel, V. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.836278 · Cited by 49
A watertight acrylic-free titanium recording chamber for electrophysiology in behaving monkeys
Adams, D. L., Economides, J. R., Jocson, C. M., Parker, J. M., & Horton, J. C. (2011) · Journal of Neurophysiology · doi:10.1152/jn.00405.2011 · Cited by 49
“These organisms are normal primate skin flora (Kluytmans et al. 1997).”
BackgroundTherapeutic efficacy of Lactobacillus acidophilus against bacterial isolates from burn wounds
Jebur, M. S. (2010) · North American Journal of Medical Sciences · doi:10.4297/najms.2010.2586 · Cited by 49
Anti-staphylococcal activities of lysostaphin and LytM catalytic domain
Sabała, I., Jonsson, I., Tarkowski, A., & Bochtler, M. (2012) · BMC Microbiology · doi:10.1186/1471-2180-12-97 · Cited by 49
“aureus carriage in hospital staff is demonstrably effective in reducing infection rates in surgical patients and those on hemodialysis [28], a lysostaphin cream to treat infected, but asymptomatic hospital staff, has potential.”
BackgroundCHOWDHARY, V. R., Tilahun, A. Y., Clark, C. R., Grande, J. P., & Rajagopalan, G. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201097 · Cited by 49
Prävention postoperativer Infektionen im Operationsgebiet
Krinko (2007) · Publication server of the Robert Koch Institute (Robert Kock Institute) · doi:10.25646/147 · Cited by 49
Saleh, K., & Schmidtchen, A. (2015) · Dermatologic Surgery · doi:10.1097/dss.0000000000000364 · Cited by 48
“Other studies show that about 60% of the population carries the bacterium intermittently, whereas 20% are never colonized.(13) Studies within dermatologic surgery have shown that reducing nasal colonization of S.”
BackgroundSchwarzkopf, R. M., Takemoto, R. C., Immerman, I., Slover, J. D., & Bosco, J. A. (2010) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.i.00991 · Cited by 48
Current knowledge about and recommendations for ocular methicillin-resistant Staphylococcus aureus
Mah, F. S., Davidson, R., Holland, E. J., Hovanesian, J. A., John, T., Kanellopoulos, J. A., Shamie, N., Starr, C. E., Vroman, D. T., & Kim, T. (2014) · Journal of Cataract & Refractive Surgery · doi:10.1016/j.jcrs.2014.09.023 · Cited by 48
“Approximately 20% of the population carry S aureus persistently, 60% are intermittent carriers, and 20% are noncarriers who rarely harbor S aureus.(3) Historically, MRSA pathogens were almost exclusively isolated from hospitals or hospital-associated facilities.”
BackgroundInfluentialBazaid, A. S., Forbes, S., Humphreys, G. J., Ledder, R. G., provided, R. O. N., & McBain, A. J. (2018) · Scientific Reports · doi:10.1038/s41598-018-21925-6 · Cited by 48
“Coupled with the colonisation of almost a third of the general population 2 , the ability to cause recurrent infections, and antibiotic resistance, S. aureus treatment is increasingly challenging.”
Karinou, E., Schuster, C. F., Pazos, M., Vollmer, W., & Gründling, A. (2018) · Journal of Bacteriology · doi:10.1128/jb.00574-18 · Cited by 48
“25) 4 (4, 4, 4) 1 (1, 1, 1) 8–16 (16, 8, 8) S7-vraT 0.”
Zeden, M. S., Kviatkovski, I., Schuster, C. F., Thomas, V. C., Fey, P. D., & Gründling, A. (2020) · Molecular Microbiology · doi:10.1111/mmi.14479 · Cited by 43
Verhoeven, P. O., Grattard, F., Carricajo, A., Lucht, F., Cazorla, C., Garraud, O., Pozzetto, B., & Berthelot, P. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03611.x · Cited by 48
“Staphylococcus aureus nasal carriage is the main risk factor for surgical site infection [1,26–29] and among S.”
BackgroundGavanji, S., Mohammadi, E., Larki, B., & Bakhtari, A. (2014) · Integrative Medicine Research · doi:10.1016/j.imr.2014.07.001 · Cited by 48
“×100 [1]”
Liu, Q., Wu, Q., Zhang, Y.-B., Liu, M., Hu, F., Xu, X., Zhu, D., & Ni, Y. (2009) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.09.018 · Cited by 48
Campos, J., Pires, M. F., Sousa, M., Campos, C., Costa, C. F. F. A., & Sampaio‐Maia, B. (2023) · Pathogens · doi:10.3390/pathogens12060765 · Cited by 47
“Persistent carriers generally carry one single strain at high levels of colonization over time, while intermittent carriers carry varying strains at lower levels of colonization over time [7].”
BackgroundThe Staphylococcus aureus regulatory program in a human skin-like environment
Costa, F. G., Mills, K. B., Crosby, H. A., & Horswill, A. R. (2024) · mBio · doi:10.1128/mbio.00453-24 · Cited by 47
“MRSA infection risk is correlated to nasal carriage, a reservoir from which MRSA can transiently colonize the skin (11).”
BackgroundRossi, A., & Mariwalla, K. (2012) · Dermatologic Surgery · doi:10.1111/j.1524-4725.2012.02524.x · Cited by 47
“There are also reports in the literature of Stevens Johnson Syndrome and anaphylaxis occurring with topical antibiotics.(72) It is therefore recommended that topical antibiotics be reserved for class III and IV wounds.”
BackgroundTreesirichod, A., Hantagool, S., & Prommalikit, O. (2014) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2013.12.003 · Cited by 47
Chen, C., Huang, M., Chen, H., Ke, S.-C., Li, C.-R., Wang, J.-H., & Wu, L.-T. (2011) · BMC Microbiology · doi:10.1186/1471-2180-11-98 · Cited by 47
“The frequently-encountered multi-antibiotic resistance of MRSA has become a major health problem [1,2].”
BackgroundMishra, S., & Horswill, A. R. (2017) · mSphere · doi:10.1128/msphere.00135-17 · Cited by 48
“aureus is a human commensal and colonizes approximately 20% of the population, while 60% of the population are transient carriers (4).”
BackgroundVaishampayan, A., de Jong, A., Wight, D. J., Kok, J., & Grohmann, E. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00221 · Cited by 47
Huang, M., Cheng, C., Tseng, S., Lin, Y., Lo, H., & Chen, P. (2018) · MicrobiologyOpen · doi:10.1002/mbo3.618 · Cited by 47
Kläui, A., Boss, R., & Graber, H. U. (2019) · Journal of Bacteriology · doi:10.1128/jb.00777-18 · Cited by 47
“Staphylococcus aureus is a commensal colonizer of the skin and mucous tissue of up to two-thirds of the human population (1, 2).”
BackgroundImproved characterisation of MRSA transmission using within-host bacterial sequence diversity
Hall, M. D., Holden, M. T. G., Srisomang, P., Mahavanakul, W., Wuthiekanun, V., Limmathurotsakul, D., Fountain, K., Parkhill, J., Nickerson, E. K., Peacock, S. J., et al. (2019) · eLife · doi:10.7554/elife.46402 · Cited by 47
Skin and Soft Tissue Infections in Persons Who Inject Drugs
Chambers, H. F. “. (2020) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2020.10.006 · Cited by 47
Meyer, T. C., Michalik, S., Holtfreter, S., Weiß, S., Friedrich, N., Völzke, H., Kocher, T., Köhler, C., Schmidt, F., Bröker, B. M., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.651619 · Cited by 47
Staphylococcus aureus Cell Wall Biosynthesis Modulates Bone Invasion and Osteomyelitis Pathogenesis
Masters, E. A., Muthukrishnan, G., Ho, L., Gill, A. L., Bentley, K. L. D. M., Galloway, C. A., McGrath, J. L., Awad, H. A., Gill, S. R., & Schwarz, E. M. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.723498 · Cited by 47
“Staphylococcus aureus is a ubiquitous organism of the human microbiota colonizing the nares of approximately 30% of individuals (Kluytmans et al., 1997).”
BackgroundFeng, D., Zhang, R., Zhang, M., Fang, A., & Shi, F. (2022) · Nanomaterials · doi:10.3390/nano12152636 · Cited by 47
“aureus is also a facultative anaerobe that causes superficial lesions on the surface of human skin, as well as various suppurative infections and toxinoses in humans [9].”
BackgroundSaunders, N. A., Underwood, A. P., Kearns, A., & Hallas, G. (2004) · Microbiology · doi:10.1099/mic.0.27330-0 · Cited by 47
“S. aureus is a highly adapted and extremely successful colonizer of the human nasopharynx, other mucosal surfaces and skin (Kluytmans et al., 1997; Williams, 1963).”
BackgroundBettin, A., Garcés, C. C., & Reyes, N. (2012) · The Brazilian Journal of Infectious Diseases · doi:10.1016/j.bjid.2012.06.017 · Cited by 48
Reservoirs of Staphylococcus aureus in meat sheep and dairy cattle
Mørk, T., Kvitle, B., & Jørgensen, H. J. (2011) · Veterinary Microbiology · doi:10.1016/j.vetmic.2011.08.010 · Cited by 47
Prevalence of Staphylococcus aureus Nasal Colonization in Emergency Department Personnel
Suffoletto, B. P., Cannon, E. H., Ilkhanipour, K., & Yealy, D. M. (2008) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2008.03.020 · Cited by 47
Strains of Staphylococcus aureus Obtained from Drug‐Use Networks Are Closely Linked
Quagliarello, B., Cespedes, C., Miller, M., Toro, A., Vavagiakis, P., Klein, R. S., & Lowy, F. D. (2002) · Clinical Infectious Diseases · doi:10.1086/342196 · Cited by 44
“wi h stap ylococci, and, as a result, they are at increased risk of d veloping infections with their colonizing strai [8-10].”
BackgroundAppropriateness of antibiotic treatment in intravenous drug users, a retrospective analysis
Mertz, D., Viktorin, N., Wolbers, M., Laifer, G., Leimenstoll, B. M., Flückiger, U. M., & Battegay, M. (2008) · BMC Infectious Diseases · doi:10.1186/1471-2334-8-42 · Cited by 47
Prevalence and acquisition of MRSA amongst patients admitted to a tertiary-care hospital in brazil
dos Santos, H. B., Machado, D. P., Camey, S. A., Kuchenbecker, R., Barth, A. L., & Wagner, M. B. (2010) · BMC Infectious Diseases · doi:10.1186/1471-2334-10-328 · Cited by 48
“The two risk factors found for colonization at admission in our adult patients have been reported elsewhere in the literature [25].”
BackgroundEpidemiology of Methicillin-SusceptibleStaphylococcus Aureusin the Neonatal Intensive Care Unit
Graham, P. L., Morel, A.-S., Zhou, J. J., Wu, F., Della‐Latta, P., Rubenstein, D., & Saiman, L. M. (2002) · Infection Control and Hospital Epidemiology · doi:10.1086/501993 · Cited by 47
“Routine surveillance cultures of NICU patients have fallen out of favor secondary to expense and lack of utility,(32) but targeted surveillance and typing with PFGE during periods of increased incidence can identify patient-topatient transmission caused by breakdowns in infection control practices.(33) NICU patients w…”
BackgroundYoung, L. S., & Winston, L. G. (2006) · Infection Control and Hospital Epidemiology · doi:10.1086/509837 · Cited by 47
“aureus (eg, patients with HIV infection or diabetes and those receiving dialysis) have increased overall rates of colonization.(7) Several scenario analyses were evaluated.”
BackgroundRozemeijer, W., Fink, P. S., Rojas, E. A. P., Jones, C. H., Pavliakova, D., Giardina, P. C., Murphy, E., Liberator, P., Jiang, Q. L., Girgenti, D., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0116945 · Cited by 46
“aureus is considered a risk factor for infection in certain patient populations [8] [9] [10,11] [12].”
Self-citationLiu, X., Pai, P.-J., Zhang, W., Hu, Y., Dong, X., Qian, P., Chen, D., & Lam, H. (2016) · Scientific Reports · doi:10.1038/srep19841 · Cited by 46
“proteome responses potentially related to the synergy: (1) the non-synergistic drug combination of”
BackgroundNair, R., Perencevich, E. N., Blevins, A., Goto, M., Nelson, R. E., & Schweizer, M. L. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ901 · Cited by 46
IL-1 receptor-associated kinase 1 mediates protection against Staphylococcus aureus infection
Verdrengh, M., Thomas, J. A., & Hultgren, O. (2004) · Microbes and Infection · doi:10.1016/j.micinf.2004.08.009 · Cited by 46
Staphylococcus AureusColonization and the Risk of Infection in Critically Ill Patients
Keene, A. B., Vavagiakis, P., Lee, M., Finnerty, K., Nicolls, D. J., Cespedes, C. A., Quagliarello, B., Chiasson, M. A., Chong, D. H., & Lowy, F. D. (2005) · Infection Control and Hospital Epidemiology · doi:10.1086/502591 · Cited by 46
Burgui, S., Gil, C., Solano, C., Lasa, I., & Valle, J. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00342 · Cited by 45
“…Microbiology | www.frontiersin.org 1 March 2018 | Volume 9 | Article 342 Staphylococcus aureus is a frequent etiological agent of DRI, especially those related with intravascular catheters, prosthetic joints, vascular grafts and pacemakers (Kluytmans et al., 1997; Lowy, 1998; Ellis et al., 2014).”
BackgroundColonization of nursing professionals by Staphylococcus aureus
de Moura, J. P., Pimenta, F. C., Hayashida, M., Cruz, E. D. D. A., Canini, S. R. M. D. S., & Gir, E. (2011) · Revista Latino-Americana de Enfermagem · doi:10.1590/s0104-11692011000200014 · Cited by 45
“Contudo, aproximadamente 60% são considerados carreadores intermitentes e os demais nunca se mostram colonizados(6).”
BackgroundGardella, N., Murzicato, S., Gregorio, S. D., Cuirolo, A., Desse, J., Crudo, F., Gutkind, G., & Mollerach, M. E. (2011) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2011.03.019 · Cited by 45
“High prevalence of MRSA colonization among hospital patients or in long-term care facilities has been well documented all over the world (Eveillard et al., 2008; Kluytmans et al., 1997).”
BackgroundResultInfluentialDecolonization therapy in infection control
Hebert, C. L., & Robicsek, A. A. (2010) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e32833ae214 · Cited by 45
Ramos, N. L., Stachel, A. G., Phillips, M., Vigdorchik, J. M., Slover, J. D., & Bosco, J. A. (2016) · Journal of the American Academy of Orthopaedic Surgeons · doi:10.5435/jaaos-d-16-00165 · Cited by 45
Community-acquired methicillin-resistant Staphylococcus aureus can persist in the throat
Hamdan‐Partida, A., González-García, S., García, E. D. L. R., & Bustos‐Martínez, J. (2018) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2018.04.002 · Cited by 45
Mnich, M. E., van Dalen, R., Gerlach, D., Hendriks, A., Xia, G., Peschel, A., van Strijp, J. A. G., & van Sorge, N. M. (2019) · Cellular Microbiology · doi:10.1111/cmi.13072 · Cited by 45
Influence of oral conditions on colonization by highly toxigenic Staphylococcus aureus strains
Passariello, C., Puttini, M., Iebba, V., Pera, P., & Gigola, P. (2011) · Oral Diseases · doi:10.1111/j.1601-0825.2011.01889.x · Cited by 45
Epidemiologic and Economic Effect of Methicillin-Resistant Staphylococcus aureus in Obstetrics
Beigi, R. H., Bunge, K. E., Song, Y., & Lee, B. Y. (2009) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e3181a116e4 · Cited by 45
Andrews, J. I., Fleener, D. K., Messer, S. A., Kroeger, J. S., & Diekema, D. J. (2009) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2009.06.062 · Cited by 45
Mupirocin resistance in clinical isolates of staphylococci in a tertiary care centre in south India
Oommen, S., Appalaraju, B., & Jinsha, K. (2010) · Indian Journal of Medical Microbiology · doi:10.4103/0255-0857.71825 · Cited by 45
“[2] The commonly used antibiotic for treatment of MRSA infection is vancomycin or linezolid, while mupirocin (derived from Pseudomonas fluorescens) is an effective topical antibiotic for the elimination of MRSA in carriers.”
BackgroundMatoušková, I., & Janout, V. (2008) · Biomedical Papers · doi:10.5507/bp.2008.030 · Cited by 45
Moran, J. C., Alorabi, J. A., & Horsburgh, M. J. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00033 · Cited by 45
“Understanding skin survival mechanisms of staphylococci is vital, as individuals colonized by Staphylococcus aureus are at greater risk of infections during hospitalization (Kluytmans et al., 1997; Davis et al., 2004).”
BackgroundMRSA – what is it, and how do we deal with the problem?
Barrett, J. F. (2005) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.9.2.253 · Cited by 45
“Targets (2005) 9(2) groin and virtually any skin surface [112].”
BackgroundRifampin, a Useful Drug for Nonmycobacterial Infections
Vesely, J. J. K., Pien, F. D., & Pien, B. C. T. (1998) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1998.tb03861.x · Cited by 43
Lowy, F. D., & Miller, M. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(02)00395-x · Cited by 45
Antibiotic overuse and resistance in dermatology
Chon, S. Y., Doan, H. Q., Mays, R. M., Singh, S., Gordon, R., & Tyring, S. K. (2012) · Dermatologic Therapy · doi:10.1111/j.1529-8019.2012.01520.x · Cited by 46
Torres, E. G., Lindmair-Snell, J., Langan, J. W., & Burnikel, B. G. (2015) · The Journal of Arthroplasty · doi:10.1016/j.arth.2015.09.030 · Cited by 44
Popovich, K. J., & Hota, B. N. (2008) · Dermatologic Therapy · doi:10.1111/j.1529-8019.2008.00188.x · Cited by 44
“aureus (22), MRSA can colonize additional body sites.”
BackgroundA Novel Staphylococcus Podophage Encodes a Unique Lysin with Unusual Modular Design
Cater, K., Dandu, V. S., Bari, S. M. N., Lackey, K., Everett, G. F. K., & Hatoum-Aslan, A. (2017) · mSphere · doi:10.1128/msphere.00040-17 · Cited by 44
“Staphylococcus aureus causes moderate to fatal infections in a variety of body sites (2), and asymptomatic nasal carriage in over 25% of the population constitutes a major public health risk (3, 4).”
BackgroundYang, J.-J., Chang, T., Jiang, Y., Kao, H.-J., Chiou, B., Kao, M., & Huang, C. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19051290 · Cited by 46
“Staphylococcus aureus is a Gram-positive bacteria that colonizes the nasal cavity of 20–30% of the human population without causing any apparent disease [1].”
Nadimpalli, M. L., Stewart, J. R., Pierce, E., Pisanic, N., Love, D. C., Hall, D., Larsen, J., Carroll, K. C., Tekle, T., Perl, T. M., et al. (2018) · Environmental Health Perspectives · doi:10.1289/ehp3453 · Cited by 44
“Colonization with livestock-associated S. aureus can supplement or replace human-adapted S. aureus (Nadimpalli et al. 2015; Verkade et al. 2013), which persistently colonize the nasal cavities of approximately 20% of the general population (Kluytmans et al. 1997).”
Elward, A. M., McAndrews, J. M., & Young, V. L. (2009) · Aesthetic Surgery Journal · doi:10.1016/j.asj.2009.01.010 · Cited by 45
Does the Nose Know? An Update on MRSA Decolonization Strategies
Abad, C. L. R., Pulia, M. S., & Safdar, N. (2013) · Current Infectious Disease Reports · doi:10.1007/s11908-013-0364-y · Cited by 44
Metadata
- Authors
- Kluytmans, J., van Belkum, A., & Verbrugh, H.
- Affiliations
- Ignatius Hospital (NL)
- Ignatius Hospital Breda, The Netherlands.
- ORCID
- Kluytmans, J
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 1997-07
- Volume
- 10
- Issue
- 3
- Pages
- 505-520
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- PMC
- PMC172932
- OpenAlex
- W2111113492
- Cited by
- 2,595
- References
- 217
- Citations by year
- 2026: 38 · 2025: 58 · 2024: 77 · 2023: 73 · 2022: 103 · 2021: 92 · 2020: 99 · 2019: 126 · 2018: 116 · 2017: 152 · 2016: 166 · 2015: 137 · 2014: 162 · 2013: 179 · 2012: 134
- FWCI
- 14.58
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Clinical Microbiology Reviews (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Infectious Diseases › Infection Control in Healthcare
- Health Sciences › Medicine › Infectious Diseases › Otolaryngology and Infectious Diseases
- Keywords
- Staphylococcus aureus, nasal carriage, methicillin-resistant Staphylococcus aureus, persistent carriage, infection risk factors, hemodialysis, continuous ambulatory peritoneal dialysis, people who inject drugs, HIV infection, surgical patients, intravascular devices, infection control
- MeSH terms
- Bacterial Adhesion, Carrier State, Endothelium, Endothelium, Corneal, Epithelium, Renal Dialysis, Humans, Peritoneal Dialysis, Continuous Ambulatory, Risk Factors, Staphylococcal Infections, Staphylococcus aureus, Surgical Wound Infection, HIV Infections
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.